Should β-blockers be used in septic shock?

Comment

Alena Lira et al. Crit Care. 2014.

. 2014 May 19;18(3):304.

doi: 10.1186/cc13878.

No abstract available

Comment on

Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial.
Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, Orecchioni A, D'Egidio A, D'Ippoliti F, Raffone C, Venditti M, Guarracino F, Girardis M, Tritapepe L, Pietropaoli P, Mebazaa A, Singer M. Morelli A, et al. JAMA. 2013 Oct 23;310(16):1683-91. doi: 10.1001/jama.2013.278477. JAMA. 2013. PMID: 24108526 Clinical Trial.

1. de Montmollin E, Aboab J, Mansart A, Annane D. Bench-to-bedside review: Beta-adrenergic modulation in sepsis. Crit Care. 2009;13:230. doi: 10.1186/cc8026. - DOI - PMC - PubMed
1. Träger K, Radermacher P, Debacker D, Vogt J, Jakob S, Ensinger H. Metabolic effects of vasoactive agents. Curr Opin Anaesthesiol. 2001;14:157–163. doi: 10.1097/00001503-200104000-00006. - DOI - PubMed
1. Pinsky MR. Is there a role for β-blockade in septic shock? JAMA. 2013;310:1677–1678. doi: 10.1001/jama.2013.278478. - DOI - PubMed
1. Dünser MW, Hasibeder WR. Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med. 2009;24:293–316. doi: 10.1177/0885066609340519. - DOI - PubMed
1. Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med. 1984;100:483–490. doi: 10.7326/0003-4819-100-4-483. - DOI - PubMed